
Photo: Depositphotos
Jun 1, 2025, 06:36
Sid Sadler: New Era for Renal Cell Carcinoma Patients
Sid Sadler, Cancer Survivor, posted on X:
“A new era for renal cell carcinoma patients!
At ASCO2025, research on predictive biomarkers was shared, focusing on tailoring treatments like pembrolizumab and axitinib for better outcomes. This means more personalized care and hope for those battling advanced RCC.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20